Here’s why private equity backed IPOs almost always fail
There have been way too many private equity backed IPOs that have turned out to be absolute duds for investors,…
Read More
Truscreen (ASX:TRU): Taking a radical path to wide-spread commercialisation
Truscreen (ASX:TRU) is not taking the conventional path ASX medtech stocks take to market. Typically they seek approval in the…
Read More
ClearVue Technologies (ASX:CPV): About to make big bucks from solar generating glass
ClearVue Technologies (ASX:CPV) may be one of the best ways for investors to gain exposure to the decarbonisation thematic. This…
Read More